Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Response to RFI on Gene Therapies Access for Rare Diseases
-
Sign-on Letter Concerning the Improving Care and Access to Nurses Act
-
ACMG Comment to NCD on Germline Editing and Impact on People with Disabilities
-
Sign-on Letter Opposing Cigna Policy on Use of Modifier -25
-
Group Sign-on Letter Concerning the Improving Care and Access to Nurses (I CAN) Act
-
Sign-on Letter Concerning Patent Legislation Negotiation Process
-
Group Sign-On Letter Concerning the VA Supremacy Project
-
Group Sign-on Letter Concerning VA Development of National Standards of Practice
-
Group Letter to Biden Administration Regarding Patent Eligibility Reform
-
Understanding the Details: ACMG’s Position on the Access to Genetic Counselor Services Act